Relief Therapeutics Holding Stock Investor Sentiment

RLFTY Stock  USD 4.80  0.20  4.00%   
Slightly above 62% of Relief Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Relief Therapeutics Holding suggests that many traders are alarmed regarding Relief Therapeutics' prospects. Relief Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Relief Therapeutics' earnings reports, geopolitical events, and overall market trends.
  
over a month ago at news.google.com         
Relief Therapeutics to merge with Renexxion - USA Herald
Google News at Macroaxis
over two months ago at news.google.com         
Relief Therapeutics Holding SA Announces Promising Preliminary Results of RLF-TD011 Clinical Trial i...
Google News at Macroaxis
over two months ago at news.google.com         
Target Price Raised on Biotech Co. - Streetwise Reports
Google News at Macroaxis
over two months ago at news.google.com         
Relief Therapeutics Holding SA Secures 2 Million Milestone Payment Under Royalty Agreement with SWK ...
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study Topline Results Exp...
Google News at Macroaxis
over three months ago at news.google.com         
Were Interested To See How Relief Therapeutics Holding Uses Its Cash Hoard To Grow - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics Reports Half-Year 2024 Financial Results and Provides Corporate Update - Yahoo F...
Google News at Macroaxis
over three months ago at news.google.com         
TNXP - Tonix Pharmaceuticals Holding Corp. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Holding First Half 2023 Earnings CHF5.10 loss per share - Yahoo Canada Shine On
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Announces New Executive Leadership Team strengthening capabilities to guide the ...
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics has Published its Annual Report - Investing.com India
Google News at Macroaxis
over six months ago at news.google.com         
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting - AccessWire
Google News at Macroaxis
over six months ago at news.google.com         
Biopharmas New Drug for COPD Likely to be Approved Research Report - Streetwise Reports
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceutical...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Relief Therapeutics that are available to investors today. That information is available publicly through Relief media outlets and privately through word of mouth or via Relief internal channels. However, regardless of the origin, that massive amount of Relief data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Relief Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Relief Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Relief Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Relief Therapeutics alpha.

Relief Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Relief OTC Stock Analysis

When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.